Traditional clinical trials are burdened with excessive administrative work, slow recruitment, fragmented data management, and compliance challenges, all of which lead to costly delays and high failure rates. For example, 84% of trials are either delayed or fail because of low patient engagement.
Research Grid is the automation engine for admin-free clinical trials that can enable faster, more successful clinical trials. Their software safely automates back-office admin across the full lifecycle of the trial to support a variety of trial types and therapeutic areas.
Wasim Khan is the Chief Technology Officer (CTO) at Research Grid, responsible for leading the company’s technology strategy and innovation. Through the Shott Scale Up Accelerator he wants to learn from experienced leaders through access to mentors and industry experts to help with scaling AI-driven products, leading high-performance teams, and managing strategic growth.
He also recognises the importance of expanding his industry network. Engaging with the Shott Scale Up Accelerator network will allow him to learn best practices, explore potential partnerships, and attract top talent for Research Grid’s engineering and AI teams.
Over the next year, his focus as CTO of Research Grid is to drive scalable AI innovation, optimise their product infrastructure, and solidify their position as the leading automation platform for clinical trials. Commercially, they aim to increase their market share, ensuring they have the resources to drive innovation and expansion. They are also prioritising customer feedback driven product improvements, particularly from clinical research institutions, to better address their most pressing needs. A critical component of this is a continuous refinement of Research Grid’s AI algorithms to reduce manual processes and enhance decision-making accuracy. They also plan to deepen their presence in both the US and Asia by tailoring our solutions to meet the specific regional and regulatory demands of each region.
